Prospective atom-based 3D-QSAR model prediction, pharmacophore generation, and molecular docking study of carbamate derivatives as dual inhibitors of AChE and MAO-B for Alzheimer’s disease
- 25 August 2013
- journal article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 23 (3) , 1114-1122
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Oxidative stress in Alzheimer diseaseCell Adhesion & Migration, 2009
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- A Century of Alzheimer's DiseaseScience, 2006
- PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database SearchingChemical Biology & Drug Design, 2006
- Cholinergic–serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer’s diseaseNeuropsychologia, 2005
- Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of theN-Propargylaminoindan ClassJournal of Medicinal Chemistry, 2004
- Low monoamine oxidase B in peripheral organs in smokersProceedings of the National Academy of Sciences, 2003
- Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARsJournal of Medicinal Chemistry, 2000
- Alzheimer's disease: more than a ‘cholinergic disorder' — evidence that cholinergic–monoaminergic interactions contribute to EEG slowing and dementiaBehavioural Brain Research, 2000
- Oxidative Stress, Glutamate, and Neurodegenerative DisordersScience, 1993